- "Disappointing" is the theme as the sell-side comments on IBM's Q4 results from last night.
- "No near-term relief" is the title of Deutsche's note (and Deutsche is a bull on the stock). The company is likely to remain in the "penalty box" until it can show evidence of stability in hardware and improved execution in emerging markets and China.
- Investors will likely mull over whether IBM will need to reset the 2015 Roadmap this spring, says JPMorgan, expecting shares to be under pressure near-term and lowering the PT to $175.
- Credit Suisse reiterates its Sell rating and $160 price target on the weaker-than-expected numbers.
- Shares -3.2% premarket
at CNBC.com (Nov 18, 2014)